Johns Hopkins Kimmel Cancer Center Completed Phase I Trial of Intravenous Mistletoe

BelieveBigPress Release

Non-profit Believe Big funded research shows mistletoe treatment safe and improves quality of life for cancer patients. Hunt Valley, Maryland — February 23, 2023 — The first mistletoe therapy clinical trial in the United States utilizing intravenous Mistletoe has been completed by oncologists at the Johns Hopkins Kimmel Cancer Center. Spearheaded by Believe Big, a non-profit cancer assistance organization founded … Read More

First U.S. Study of Mistletoe Extract to Treat Cancer – Johns Hopkins Kimmel Cancer Center – Press Release

BelieveBigPress Release

First U.S. Study of Mistletoe Extract to Treat Cancer Mistletoe extract has been widely used to support cancer therapy and improve quality of life, but questions remain due to a lack of clinical trials and data to support its use. Researchers at the Johns Hopkins Kimmel Cancer Center completed the first Phase I intravenous trial in the U.S. aimed at … Read More